| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/28/2002 | CN1365699A Nano health-medicine for tonifying kidney and its preparing process |
| 08/28/2002 | CN1365692A Nano phellodendron bark medicine and its preparing process |
| 08/28/2002 | CN1365689A Nano medicine 'Jiuyisan' and its preparing process |
| 08/28/2002 | CN1365686A Nano clove medicine and its preparing process |
| 08/28/2002 | CN1365664A Medicine for removing vegetation from human body and its preparing process and application |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/28/2002 | CN1089762C Benzimidazole compounds and their use as modulators of GABAA receptor complex |
| 08/27/2002 | US6441212 Silanol enzyme inhibitors |
| 08/27/2002 | US6441188 Aminoaryl oxazolidinone N-oxides |
| 08/27/2002 | US6441183 Useful as an intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases |
| 08/27/2002 | US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/27/2002 | US6441165 Process for the preparation of 11-amino-3-chloro-6, 11-dihydro-5, 5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine and application to the synthesis of tianeptine |
| 08/27/2002 | US6441149 Isolated nucleic acids |
| 08/27/2002 | US6441138 Protein which induces interferon-γ production by immunocompetent cell |
| 08/27/2002 | US6441048 Methods of treating affective disorders using derivatives of (-)-venlafaxine |
| 08/27/2002 | US6441038 Treatment of fatigue, head injury and stroke |
| 08/27/2002 | US6441036 Treating atherosclerosis and insulin resistance |
| 08/27/2002 | US6441026 And an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, an enzyme, a topoisomerase inhibitor, a platinum coordination complex, a biological response modifier or a growth factor inhibitor |
| 08/27/2002 | US6441019 Cyclocarbamate and cyclic amide derivatives |
| 08/27/2002 | US6441017 Inhibitors of prenyl-protein transferase |
| 08/27/2002 | US6441015 Tetrazole compounds as thyroid receptor ligands |
| 08/27/2002 | US6441014 Antiinflammatory agent, useful for treating cylcoocygenase-2 associated disorders |
| 08/27/2002 | US6441012 Chemical compounds |
| 08/27/2002 | US6441008 Benzamide derivatives as thrombin inhibitors |
| 08/27/2002 | US6441007 Treating central nervous system disorders with pyridyloxylalkylamines and phenoxyalkylamines |
| 08/27/2002 | US6441006 Pharmaceutical compositions and methods for use |
| 08/27/2002 | US6441004 Monocyte chemoattractant protein-1 inhibitor compounds |
| 08/27/2002 | US6441002 The potent and selective cyclooxygenase-2 (cox-2) inhibitor etoricoxib |
| 08/27/2002 | US6441000 Compounds useful in therapy |
| 08/27/2002 | US6440998 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative |
| 08/27/2002 | US6440996 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 08/27/2002 | US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 08/27/2002 | US6440982 Inhibitors of cyclic guanosine monophosphate diesterases |
| 08/27/2002 | US6440979 Aryl isoguanines |
| 08/27/2002 | US6440968 Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines |
| 08/27/2002 | US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors |
| 08/27/2002 | US6440962 Cardiovascular disorders, antiischemic agents |
| 08/27/2002 | US6440960 An oxygen or sulfure or sulfure oxide or dioxide containing tricyclic compouund useful for treating the disorder manifesting hypersecretion of corticotropin releasing factor |
| 08/27/2002 | US6440958 Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440948 Thiophene A2A receptor agonists |
| 08/27/2002 | US6440947 Coadministration of an adenosine a2 receptor agonist, e.g., adenosine and heparin or heparin-like compound to improve collateral coronary circulation in patients suffering from myocardial infarction; angiogenisis |
| 08/27/2002 | US6440944 Methods of administering adenoviral vectors |
| 08/27/2002 | US6440939 Thrombin inhibitors |
| 08/27/2002 | US6440938 Prevention and/or treatment of allergic conditions |
| 08/27/2002 | US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents |
| 08/27/2002 | US6440935 Such as cecropins and sarcotoxins |
| 08/27/2002 | US6440742 Recombinant AAV vector-based transduction system and use of same |
| 08/27/2002 | US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy |
| 08/27/2002 | US6440468 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
| 08/27/2002 | US6440455 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 08/27/2002 | US6440454 Supersaturated solution of estradiol, progestogen, and activated silica; outer backing foil and protective lining |
| 08/27/2002 | US6440413 Selectively destroying subunit a without destroying subunit b of cholera toxin; enzyme with preponderance of exocellular proteinase produced by a culture of streptomyces fradiae; hyperviscosity of intestinal, bronchial and/or genital mucus |
| 08/27/2002 | US6440407 Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides |
| 08/27/2002 | US6440387 For decreasing blood cholesterol levels, thereby decreasing risk for developing alzheimer's disease; for post menopausal women |
| 08/27/2002 | CA2173939C Oligopeptides derived from c-reactive protein fragments |
| 08/27/2002 | CA2167039C Alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them |
| 08/27/2002 | CA2125888C Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 08/27/2002 | CA2101548C Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
| 08/27/2002 | CA2069929C Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 08/27/2002 | CA2062837C 8-substituted purines as selective adenosine receptor agents |
| 08/27/2002 | CA2045955C Indole derivatives |
| 08/27/2002 | CA2033392C A-nor-steroid-3-carboxylic acid derivatives |
| 08/27/2002 | CA2032311C 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064791A2 Proteins and nucleic acids encoding same |
| 08/22/2002 | WO2002064786A1 Novel gene tcif |
| 08/22/2002 | WO2002064785A1 NOVEL CLOCK GENE Bmal2 |
| 08/22/2002 | WO2002064772A1 Human nmda receptor splice variant |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064635A1 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 08/22/2002 | WO2002064629A2 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
| 08/22/2002 | WO2002064627A2 Crystallization of igf-1 |
| 08/22/2002 | WO2002064625A1 Matrix gene expression in chondrogenesis |
| 08/22/2002 | WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | WO2002064606A1 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 08/22/2002 | WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064598A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064595A1 Triazolo compounds as mmp inhibitors |
| 08/22/2002 | WO2002064590A2 Carboline derivatives |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors |
| 08/22/2002 | WO2002064580A1 Lactone compounds as novel photoinitiators |
| 08/22/2002 | WO2002064578A1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/22/2002 | WO2002064572A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | WO2002064571A1 Pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064568A1 Pyridine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064564A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor |
| 08/22/2002 | WO2002064563A1 Novel benzoylguanidine salt |
| 08/22/2002 | WO2002064557A2 New crystal forms of oxcarbazepine and processes for their preparation |
| 08/22/2002 | WO2002064552A1 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES |
| 08/22/2002 | WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives |
| 08/22/2002 | WO2002064549A1 Ppar agonists |
| 08/22/2002 | WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |